Ergomed's PeproStat meets in Phase II for intraoperative surgical bleeding

In October, Ergomed plc (LSE:ERGO) reported top-line data from a Phase II trial to treat intraoperative surgical bleeding in 169 patients undergoing liver/soft tissue,

Read the full 246 word article

User Sign In